The Role of Inflammation in Venous
Disease
PD Coleridge Smith FRCS, CM Butler RGN, JH Scurr
FRCS,
Department of Surgery, University College London
Medical School, The Middlesex Hospital, Mortimer
Street, London W1N 8A
Contents
Abstract
Venous valvular incompetence is present in up
to 10% of the population of Western countries
and 0.2% have venous ulceration as a consequence.
It is generally agreed that sustained venous
hypertension is an essential pre-requisite
to the development of ulcers but the precise
patho-physiological mechanism remains obscure.
Various theories of the aetiology of venous
ulceration have been put forward, of which
the two currently most popular are the fibrin
cuff theory of Browse and Burnand and the white
cell trapping theory of Coleridge Smith et
al. Research has failed to show that fibrin
cuffs present a diffusion barrier to the passage
of oxygen "and other nutrients",
and cutaneous oxygen tension is actually higher
in patients with venous disease. The white
cell trapping hypothesis suggests that increased
venous pressure causes a reduction in capillary
blood flow, resulting in trapping of the white
blood cells in the leg. These cells may plug
the capillaries, resulting in areas of localised
ischaemia, and become activated, releasing
toxic oxygen metabolites (free radicals), proteolytic
enzymes and chemotactic substances. White cell
margination has been shown to occur in the
post-capillary venules when blood flow is reduced,
and increased numbers of white cells have been
demonstrated in the skin of patients with lipodermatosclerosis
(LDS) We have recently obtained direct evidence
for the release of products of white cell activation
in venous disease. An understanding of the
mechanisms responsible for venous ulceration
may lead to the development of improved methods
of treatment.
The "White Cell Trapping" hypothesis.
The search for the mechanisms of skin damage
in venous disease has resulted in investigation
of the blood. Moyses et al studied the limbs
of normal subjects in response to raised venous
pressure, and measured haematological parameters
as an index of the effect of the venous hypertension
. Their subjects sat on a bicycle saddle with
the limbs dependent for a period of forty minutes
without moving. Blood samples were taken from
the long saphenous vein at the ankle. He found
that the haematocrit and red cell count increased
in parallel. However, the white cell count remained
unchanged, despite the increased haematocrit.
White cells were being 'lost' from the circulation,
which after 40 minutes accounted for a 25% change
in the white cell count. Thomas performed a similar
study in which he compared patients with normal
lower limbs to those of patients with venous
disease resulting in lipodermatosclerosis and
ulceration . Their patients sat with their legs
dependent, a less stringent requirement than
that of Moyses et al. Blood samples were taken
from the long saphenous vein at the ankle. After
60 minutes patients with venous disease were
'trapping' 30% of the white cells and control
subjects were trapping 7%. The white cells were "released" when
patients lay supine. This lead us to examine
the microcirculation using capillary microscopy.
The number of visible capillary loops per unit
area was determined in patients with normal limbs,
varicose veins, and lipodermatosclerosis. Only
in the patients with lipodermatosclerosis were
there significant alterations in capillary counts,
where there appeared to be fewer capillary loops.
The number of loops decreased with increased
venous pressure. We suspected that this was a
consequence of the white cell trapping showed
by Thomas et al. We found that venous hypertension
appeared to reduce the number of visible capillary
loops in patients with venous disease, but not
in control subjects , suggesting that capillary
damage may occur during venous hypertension.
We published a hypothesis suggesting that white
cell trapping resulted in such processes being
triggered, causing degradation of tissues (fig
1). In keeping with the literature on myocardium
in critical ischaemia, we proposed that white
cells might cause occlusion of capillaries, a
suggestion originally made by Moyses et al1 .
If some of the capillaries were occluded this
might result in heterogeneous perfusion and therefore
tissue hypoxia and ischaemia
Bollinger et al have investigated the events
in venous disease using fluorescence video capillary
microscopy . They measured the rate of diffusion
of fluorescein out of capillaries after an intravenous
injection. They showed that capillaries in venous
disease are much more permeable than normal to
this molecule, contrary to the suggestions made
in the fibrin cuff hypothesis. Using simultaneous
fluorescence and light capillary microscopy Franzeck
et al have described the appearances of capillary
loops which are filled with red blood cells,
but do not appear to be perfused . They suggest
that this may be due to capillary 'thrombosis'.
After investigation by xenon clearance and oxygen
return times , , we have not been able to support
earlier hypotheses suggesting that venous ulceration
is due to tissue hypoxia , .
The second part of the theory proposed that
white cell activation was part of the process,
resulting in release of proteolytic enzymes,
superoxide radicals and chemotactic substances.
All classes of white cells appear to become trapped
so a wide range of phenomena is possible. Monocytes
might become activated releasing the cytokines
interleukin 1 (IL-1) and tumour necrosis factor
alpha (TNF*) . These may cause endothelial cell
activation, in which the endothelium permits
the passage of much larger molecules than would
normally be the case . Burnand discovered that
the capillaries of patients with venous disease
are much more permeable to fibrinogen than normal
. In addition, he also noticed that fibrinolysis
is decreased in patients with venous disease
. IL-1 acts on endothelial cells to stimulate
production of the fibrinolytic inhibitor plasminogen
activator inhibitor 1 (PAI-1), and decreases
the production of tissue plasminogen activator
(tPA) producing the effect on fibrinolysis that
is observed.
White cell margination is a normal event in
the arterioles, capillaries and venules. In reperfusion
injury it is thought to be important in the mechanism
that results in tissue injury following ischaemia.
White blood cells are substantially larger than
red cells and are responsible for many of the
rheological properties of blood. White cells
take 1000 times longer than red cells to deform
on entering a capillary bed, and are responsible
for about half the peripheral vascular resistance
despite their small numbers in the circulation
compared with red cells . In myocardial infarction
it has been shown that they cause capillary occlusion,
which can be prevented in experimental animals
by first rendering the animal leucopoenic , .
White blood cells have been implicated as the
mediators of ischaemia in many tissues including
myocardium, brain, lung and kidneys - . Polymorphonuclear
leukocytes, particularly those attached to capillary
endothelium, may become 'activated' in which
cytoplasmic granules containing proteolytic enzymes
are released . In addition a non-mitochondrial
'respiratory burst' permits these cells to release
free radicals, most notably, the superoxide radical,
which have non-specific destructive effects on
lipid membranes, proteins and many connective
tissue compounds . The chemotactic leukotrienes
are also released attracting more polymorphonuclear
cells.
Histological Studies
Dermatology texts on venous disease describe
infiltration of the skin by inflammatory cells.
In order to investigate this quantitatively
we took biopsies of the skin of the supra-malleolar
region of patients undergoing varicose vein
surgery. Three groups of patients were studied.
The first were patients with no evidence of
skin changes as a consequence of their venous
disease. The next group exhibited lipodermatosclerosis,
but there had never been ulceration of the
limb. Finally, there was a group of patients
who had had ulceration, but were left with
lipodermatosclerosis after healing of the ulcer
.
Skin biopsies were taken from the liposclerotic
area and histologic slides made. The number of
white blood cells visible in the upper 0.5mm
of the skin in each section was estimated by
an observer who was unaware of the diagnosis.
The results are shown in Figure 2. Patients with
normal skin had a low number of white blood cells
visible (4 /sq. mm) . There were eight times
as many in patients with liposclerotic skin and
40 times as many in patients with healed venous
ulcers. We have subsequently undertaken an immunohistological
study to determine the types of white cell present
in this infiltrate. The majority of cells are
macrophages with a T-lymphocyte component, but
no excess of neutrophils compared with control
sections taken from normal limbs. This infiltrate
is a reflection of a chronic inflammatory process,
and suggests that an investigation of the cell
products of these leukocytes might indicate the
mechanisms involved in venous ulceration. We
have also been able to identify IL-1 as an inflammatory
mediator in this process using immunohistochemical
methods .
White blood cell metabolism in venous disease.
Histological studies demonstrate the presence
of white cells, but do not indicate whether
they are activated. Recently McCollum has demonstrated
upregulation of neutrophil production of free
oxygen radicals and increased production of
thromboxane A2 in response to raised venous
pressure in blood taken from the leg veins
of patients with chronic venous insufficiency
(McCollum CN)
Neutrophil elastase as an indicator of neutrophil
activation.
Methods of assessing neutrophil function in the
peripheral blood have been described that depend
on the release of proteinases into the blood
by activated leucocytes - . During the process
of phagocytosis or when activated by other stimuli
such as soluble immune complexes, C5a or endotoxins,
neutrophils release several different lysosomal
proteinases, of which neutrophil elastase appears
to be the principal component , . The level of
neutrophil elastase in the peripheral blood reflects
neutrophil activity anywhere in the body and,
therefore, provides a reliable, repeatable and
relatively non-invasive measure of neutrophil
activation.
We measured plasma elastase as a marker of neutrophil
degranulation in three groups of 15 patients
with uncomplicated varicose veins, lipodermatosclerosis
(LDS) and venous ulceration and compared the
values obtained with those in age- and sex-matched
control subjects. Blood was taken from an arm
vein in all patients and control subjects for
full blood count including neutrophil count,
erythrocyte sedimentation rate and plasma neutrophil
elastase, measured using a radio-immunoassay.
Higher levels of elastase were found in all patient
groups compared to their controls (median 25.6
ng/ml. for uncomplicated varicose veins, controls
18 ng/ml., 22.1 ng/ml. for patients with lipodermatosclerosis,
controls 17.7 ng/ml., and 26 ng/ml. for patients
with venous ulceration, controls 18.8 ng/ml.),
reaching statistical significance for all three
groups (fig 3). There was no difference in the
neutrophil count between the patient and control
groups. This provides evidence of increased neutrophil
degranulation in patients with venous disease,
and the finding of raised levels in all three
patient groups shows that this was not solely
due to the inflammatory process found in LDS
and venous ulceration. It is likely that the
cause for this is neutrophil activation within
the lower limb caused by venous hypertension.
Plasma Lactoferrin levels as indicators of neutrophil
activation.
Plasma lactoferrin levels have been used as an
indicator of neutrophil activation in several
disease states including dental pulp disease
, various forms of arthritis , and sepsis . This
glycoprotein is found in several glandular epithelial
tissues and human neutrophils, where it is localised
to secondary granules. We measured plasma lactoferrin
as a marker of neutrophil degranulation in groups
of 10 patients with varying severity of venous
disease and age- and sex-matched control subjects.
We investigated 4 groups of patients with varicose
veins, liposclerotic skin changes, active ulceration
and healed ulcers compared to groups of control
subjects with no history or clinical findings
of venous disease.
Blood was taken from an arm vein for neutrophil
count and plasma lactoferrin, measured using
an enzyme-linked immunosorbant assay (ELISA).
We found significantly raised plasma lactoferrin
in all four groups of patients compared to their
controls (p=.0156 for uncomplicated varicose
veins, p=.01 for lipodermatosclerosis, p=.0413
for active venous ulceration, and p=.0005 for
healed ulcers, Mann-Whitney U Test. Difference
between medians (95% confidence interval) for
the four groups were 269(62-603), 199(60-314),
133(44-218) and 215(98-349) ng/ml respectively).
There was no difference in the neutrophil count
between the patient and control groups. This
study shows further evidence of increased neutrophil
activation demonstrated by increased neutrophil
degranulation in patients with venous disease.
Does short-term venous hypertension cause neutrophil
activation?
Venous hypertension should cause neutrophil activation
within one hour if the "white cell trapping" hypotheses
is tenable. We measured lactoferrin levels in
a group of 15 healthy normal volunteers with
no clinical evidence of venous disease using
two models of venous hypertension. A dorsal foot
vein or lower long saphenous vein of both feet
were cannulated using an 18G cannula (Venflon,
Viggo-Spectramed, Helsingborg, Sweden), together
with a vein on the dorsum of the right hand.
The cannulae were then flushed with heparinised
saline. Volunteers rested supine for 30 minutes
on a couch. Two ml of blood were taken from each
cannula and discarded, and a further 10 ml blood
taken into two EDTA tubes for analysis. A wide
pneumatic tourniquet was applied around the right
thigh and inflated to 80 mmHg for 30 minutes.
Further blood samples were taken from the three
cannulae as above, the tourniquet deflated, and
five minutes after deflation three further samples
taken. The volunteers then rested for a further
30 minute period lying supine on the couch, following
which they stood up for 30 minutes, resting against
the edge of the couch such that no movement of
the calf muscle pump was required to stay upright.
At the end of this period a fifth set of blood
samples were taken, and the experiment ended.
Direct measurement of venous pressure showed
that this protocol resulted in a pressure of
70-75 mmHg in the foot veins, without reducing
arterial pressure. An ELISA developed by Dr JB
Porter in the Department of Haematology, UCMSM,
London was then used to assess lactoferrin levels.
There was a significant rise in lactoferrin in
the right leg after application of a tourniquet
for 30 minutes but not in the left leg or arm
(fig 4a).
During the second part of the experiment (standing
for 30 minutes), lactoferrin levels increased
significantly in all three limbs. The data for
both legs added together show a rise in plasma
lactoferrin (difference between medians 5.73
ng/ml, 95% confidence interval 1.2 to 10 ng/ml)
(fig. 4b). These data confirm that short term
venous hypertension results in neutrophil degranulation,
in subjects with no evidence of venous disease.
We propose that in patients with venous valvular
damage, repeated exposure of the lower limb to
neutrophil activation may initiate the trophic
skin changes seen in chromic venous insufficiency.
Conclusions
The precise mechanisms through which venous hypertension
causes ulceration still remain unclear. Our
investigation of white blood cell metabolism
leads us to suspect that neutrophil activation
may play an important role in initiating skin
damage in patients with chronic venous insufficiency.
A better understanding of the processes initiating
this problem may lead to improvements in the
management of patients with venous ulceration.
Acknowledgements
Our grateful thanks to the following members
of the Department of Surgery of University College
London Medical School who have undertaken much
of the work described in this paper and made
substantial intellectual contribution to our
understanding of venous disease: Mr TR Cheatle,
Mr HJ Scott, Mr DA Shields and Mr A Andaz.
Figure legends
Fig. 1 The 'White cell trapping' hypotheses
summarised diagramatically.
Fig. 2. Results of quantitative histological
study published by Scott 24. The vertical axis
shows the number of white blood cells counted
per square millimetre of histological section
in the upper 1mm of the dermis.
Fig. 3 Results of measurement of plasma neutrophil
elastase levels in patients with venous disease
and control subjects (fig 3a). In fig 3b patients
and age matched controls have been separated
into those with uncomplicated varicose veins
(VVs), lipodermatosclerosis (LDS) and active
ulceration (Ulcer). Descriptors are medians and
inter-quartile ranges.
Fig 4. Results of measurement of plasma neutrophil
lactoferrin levels in normal volunteers subjected
to experiment venous hypertension. Results are
expressed at lactoferrin corrected for neutrophil
count (ng/ml/109 neutrophils/l). Fig 4a shows
the effect of 30 minutes of venous hypertension
applied to the right lower limb using a cuff.
Fig 4b shows the effect of standing for 30 minutes
to produce venous hypertension. Numerical data
is the median difference between data groups
and the 95% confidence interval (95% CI).
References
Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration
and the accumulation of white cells in the feet
during venous stasis. Int J Microcirc: Clin Exp
1987; 5: 311-320.
Thomas PRS, Nash GB and Dormandy JA. White cell accumulation in the dependent
legs of patients with venous hypertension: a possible mechanism for trophic changes
in the skin. Br Med J 1988; 296: 1693-5.
Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. Venous ulceration and the
role of the white blood cell. J Med Sci & Tech 1990; 14:184-7.
Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration:
a new hypothesis. Br Med J 1988; 296:1726-7
Bollinger A, Haselbach P, Schnewlin G and Junger M. Microangiopathy due to chronic
venous incompetence evaluated by fluorescence videomicroscopy. Phlebology 1985;
eds Negus D and Jantet G, John Libbey & Co, London, 1986.
Franzeck UK, Speiser D, Haselbach P and Bollinger A. Morphologic and dynamic
microvascular abnormalities in chronic venous incompetence (CVI). Phlebologie
1989; eds. Davy A, Stemmer R. John Libbey Eurotext Ltd, Montrouge, France 1989,
pp104-7.
Stibe ECL, Cheatle TR, Coleridge Smith PD, Scurr JH: Liposclerotic skin: a diffusion
block or a problem? Phlebology 1990; 5:231-6
Cheatle TR, McMullin GM, Farrah J, Coleridge Smith PD, Scurr JH: Three tests
of microcirculatory function in the evaluation of treatment for chronic venous
insuffiency. Phlebology 1990; 5:165-72
Browse NL, Burnand KG. The cause of venous ulceration. Lancet; ii:243-5
Homans J. The aetiology and treatment of varicose ulcers of the leg. Surg Gynaecol
Obstet 24: 300-11, 1917.
Adams DO and Hamilton TA. The cell biology of macrophage activation. Ann Rev
Immunol 1984; 2: 283-318.
Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol
1988; 133: 426-33.
Burnand KC, Clemenson G, Whimster I, Grant J, Browse NL: The effect of sustained
venous hypertension on the skin capillaries of the canine hind limb. Br J Surg
1982; 69:51-54
Browse NL, Gray L, Jarrett PEM and Morland M. Blood and vein-wall fibrinolytic
activity in health and vascular disease. Br Med J 1977; i: 478-81.
Braide M, Amundson B, Chien S and Bagge U. Quantitative studies of leucocytes
on the vascular resistance in a skeletal muscle preparation. Microvasc Res
1984; 27: 331-352.
Engler RL, Dahlgren MD, Peterson MA, Dobbs A and Schmid-Schoenbein GW. Accumulation
of polymorphonuclear leucocytes during three hour myocardial ischemia. Am J
Physiol 1986; 251: H93-100.
Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA and Lucchesi BR. Reduction
of the extent of ischemic myocardial injury by neutrophil depletion in the
dog. Circulation 1983; 67: 1016-23.
Wilson JW. Leucocyte sequestration and morphologic augmentation in the pulmonary
network following haemorrhagic shock and related forms of stress. Adv Microcirc
1972: 197-232.
Linas SL, Shanley PF, Whittenburg D, Berger E and Repine JE. Neutrophils accentuate
ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol
1988; 255: F728-35.
Yamakawa T, Suguyama I and Niimi H. Behaviour of white blood cells in microcirculation
of the cat brain cortex during hemorrhagic shock. Intravital microscopic study.
Int J Microcirc: Clin Exp 1984; 3:554.
Braide M, Blixt A and Bagge U. Leukocyte effects on the vascular resistance
and glomerular filtration of the isolated rat kidney at normal and low flow
rates. Circulatory Shock 1986; 20: 71-80.
Weissman G, Smolen JE and Korchak HM. Release of inflammatory mediators from
stimulated neutrophils. N Engl J Med 1980; 303: 27-34.
Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood
1984; 64: 959-66.
Scot HJ, Coleridge Smith PD, Scurr JH. Histological study of white blood cells
and their association with lipodermatosclerosis and venous ulceration. Br J
Surg 1990; 78:210-11
Wilkinson LS, Bunker C, Edwards CW, Scurr JH, Coleridge Smith PD: Leukocytes:
Their role in the etiopathogenesis of skin damage in venous disease. J Vasc
Surg 1993; 17:669-75
Edwards AT, DeFriend DJ, Corson RJ, McCollum CN: Oxygen-derived free radicals
and ischaemia-reperfusion in venous ulceration. Br J Surg 1992; 79:369
Harpel PC. a2-Plasmin inhibitor and a2-macroglobulin complexes in plasma. Quantitation
by an enzyme linked differential antibody immunosorbent assay. J Clin Invest
1981; 68:46-55
Brower MS, Harpel PC. Alpha-1-Antitrypsin-Human leukocyte elastase complexes
in blood: Quantification by an enzyme linked differential immunosorbent assay
and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Blood 1983;
61:842-9
Neumann S, Gunzer G, Hennrich N, Lang H. 'PMN-elastase assay': Enzyme immunoassay
for human polymorphonuclear elastase complexed with a1-protinase inhibitor.
J Clin Chem Clin Biochem 1984; 22:693-7
Henson PM. The immunologic release of constituents from neutrophil leukocytes.
I. The role of antibody and complement on non-phagocytosable surfaces of phagocytosable
particles. J Immunol 1971; 107:1535-46
Ohlsson K, Olsson I. The extracellular release of granulocyte collagenase and
elastase during phagocytosis and inflammatory processes. Scand J Haematol 1977;
19:145-52
Rauschenberger CR, Turner DW, Kaminski EJ, Osetek EM. Human polymorphonuclear
granule components: relative levels detected by a modified enzyme-linked immunosorbent
assay in normal and inflamed dental pulps. J Endod 1991; 17:531-6.
Geborek P, Mansson B, Hellmer G, Saxne T. Cytidine deaminase and lactoferrin
in inflammatory synovial fluids. Indicators of local polymorphonuclear cell
function? Br J Rheumatol 1992; 31:235-40.
Adeyemi EO, Campos LB, Loizou S, Walport MJ, Hodgson HJ. Plasma lactoferrin
and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus.
Br J Rheumatol 1990; 29:15-20.
Nuijens JH, Abbink JJ, Wachtfogel YT et al. Plasma elastase alpha 1-antitrypsin
and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
J Lab Clin Med 1992; 119:159-68.
Devereux S, Porter JB, Hoyes KP, Abeysinghe RD, Saib R, Linch DC. Secretion
of neutrophil secondary granules occurs during granulocyte-macrophage colony
stimulating factor induced margination. Br J Haematol 1990; 74:17-23.
Contents
|